Home › Calculator › ERNA Dividend Calculator 2026
ERNA Dividend DRIP Calculator 2026
50.89% YieldHealthcareErnexa Therapeutics Inc. · NASDAQ
Price: $3.93 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ERNA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your ERNA snowball 📈
$10,000 in ERNA → $611.8K in 10 years · $17,195.53/month
About Ernexa Therapeutics Inc. (ERNA) — Dividend Analysis 2026
Ernexa Therapeutics Inc. is a biotechnology firm currently in its preclinical development phase, specializing in the creation of therapeutic interventions using induced mesenchymal stem cells (iMSCs). The company's primary focus lies in addressing solid tumor cancers and a range of autoimmune diseases. Its flagship candidate, ERNA-101, is an allogeneic iMSC designed to release pro-inflammatory cytokines, namely IL-7 and IL-15, intended for the treatment of ovarian cancer. Additionally, Ernexa is developing ERNA-102, an iMSC product engineered to secrete the anti-inflammatory cytokine IL-10, aimed at managing rheumatoid arthritis. The company has a licensing arrangement in place with Factor Bioscience Limited. Established in 2018, this Cambridge, Massachusetts-based entity operated as Eterna Therapeutics Inc. until its rebranding to Ernexa Therapeutics in March 2025.
Compare ERNA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ERNA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ERNA position with:
🌍 ERNA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ERNA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 50.89% | 48.09% | $5,089 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 43.26% | 40.46% | $4,326 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 40.71% | 37.91% | $4,071 / yr |
| 🇬🇧 UK ISA | 0% | 50.89% | 48.09% | $5,089 / yr |
| 🇬🇧 UK Taxable | 8.75% | 46.44% | 43.64% | $4,644 / yr |
| 🇨🇦 TFSA | 0% | 50.89% | 48.09% | $5,089 / yr |
| 🇨🇦 CA Taxable | 25% | 38.17% | 35.37% | $3,817 / yr |
| 🇦🇺 Super (pension) | 15% | 43.26% | 40.46% | $4,326 / yr |
| 🇦🇺 AU Taxable | 30% | 35.62% | 32.82% | $3,562 / yr |
| 🇩🇪 DE Taxable | 26.375% | 37.47% | 34.67% | $3,747 / yr |
| 🇫🇷 FR Taxable | 30% | 35.62% | 32.82% | $3,562 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ERNA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ERNA Dividend Payment Schedule
ERNA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 ERNA vs Healthcare Benchmarks
How ERNA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ERNA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ERNA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-02-10 | 4,000,000 | $0.50 | $2.00M | ||
| Buy | 2026-02-10 | 4,000,000 | $0.68 | $2.72M | ||
| M-Exempt | 2025-06-21 | 30 | — | — | ||
| M-Exempt | 2025-06-21 | 30 | — | — | ||
| Buy | 2025-06-09 | 21,241,163 | $0.10 | $2.22M | ||
| Buy | 2024-09-24 | 1,562,988 | $1.43 | $2.24M | ||
| Buy | 2024-09-24 | 5,420,823 | — | — | ||
| Buy | 2024-09-24 | 1,237,762 | $1.43 | $1.77M | ||
| Buy | 2024-09-24 | 4,768,783 | — | — | ||
| Buy | 2024-09-24 | 261,756 | $1.43 | $374.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ERNA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Ernexa Therapeutics Inc. (ERNA) is currently trading at $3.93, trading near its 52-week low. The current dividend yield is 50.89% based on an annual payout of $2.00 per share.
ERNA (Ernexa Therapeutics Inc.) — 50.89% Dividend Yield Analysis
Ernexa Therapeutics Inc. (ERNA) is a healthcare stock currently trading at $3.93 with a dividend yield of 50.89%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (50.89%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.